Esperion Therapeutics, Inc. (ESPR)

CIK 1434868 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Esperion Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G0000886982-26-000476
Jul 31, 2026SCHEDULE 13G0002100119-26-001401
Jul 23, 202615-12G0001104659-26-086097
Jul 15, 2026EFFECT9999999995-26-002305
Jul 15, 2026EFFECT9999999995-26-002302
Jul 15, 2026EFFECT9999999995-26-002303
Jul 15, 2026EFFECT9999999995-26-002307
Jul 15, 2026EFFECT9999999995-26-002304
Jul 15, 2026EFFECT9999999995-26-002301
Jul 14, 2026SCHEDULE 13G/A0000814133-26-000078
Jul 13, 2026S-8 POS0001104659-26-083006
Jul 13, 2026S-8 POS0001104659-26-083002
Jul 13, 2026S-8 POS0001104659-26-082996
Jul 13, 2026S-8 POS0001104659-26-082992
Jul 13, 2026S-8 POS0001104659-26-082988
Jul 13, 2026POS AM0001104659-26-083010
Jul 13, 2026POS AM0001104659-26-083009
Jul 13, 2026S-8 POS0001104659-26-082999
Jul 13, 2026S-8 POS0001104659-26-082995
Jul 13, 202625-NSE0001354457-26-000668
Jul 13, 2026S-8 POS0001104659-26-082991
Jul 13, 20268-K0001104659-26-082926
Jul 13, 2026S-8 POS0001104659-26-082987
Jul 13, 2026S-8 POS0001104659-26-082990
Jul 13, 2026S-8 POS0001104659-26-082998